CymitQuimica logo

N-Boc-Aliskiren

CAS:

Ref. TR-A536015

100mg
2,087.00€
N-Boc-Aliskiren
TRC

    Product Information

    Name:N-Boc-Aliskiren
    Controlled Product
    Synonyms:
    • N-[(1S,2S,4S)-4-[[(3-Amino-2,2-dimethyl-3-oxopropyl)amino]carbonyl]-2-hydroxy-1-[(2S)-2-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-3-methylbutyl]-5-methylhexyl]carbamic Acid 1,1-Dimethylethyl Ester
    • Carbamic acid
    • [(1S,2S,4S)-4-[[(3-amino-2,2-dimethyl
    Brand:TRC
    Description:Applications N-Boc-Aliskiren is an impurity of Aliskiren (A536000), an orally active, synthetic nonpeptide renin inhibitor. Antihypertensive.References Lefevre, G., et al.: J. Immunoassay, 21, 65 (2000); Allikments, K., et al.: Curr. Opin. Invest. Drugs, 3, 1479 (2002); Wood; J.M., et al.: Biochem. Biophys. Res. Commun., 308, 698 (2003); Grandman, A.H., et al.: Circulation, 111, 1012 (2005)
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:651.874
    Formula:C35H61N3O8
    Color/Form:Neat
    InChI:InChI=1S/C35H61N3O8/c1-22(2)25(17-24-13-14-29(44-11)30(18-24)45-16-12-15-43-10)19-27(38-33(42)46-34(5,6)7)28(39)20-26(23(3)4)31(40)37-21-35(8,9)32(36)41/h13-14,18,22-23,25-28,39H,12,15-17,19-21H2,1-11H3,(H2,36,41)(H,37,40)(H,38,42)/t25-,26-,27-,28-/m0/s1

    Technical inquiry about: N-Boc-Aliskiren

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.